pubmed-article:11425270 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11425270 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
pubmed-article:11425270 | lifeskim:mentions | umls-concept:C0006141 | lld:lifeskim |
pubmed-article:11425270 | lifeskim:mentions | umls-concept:C0405352 | lld:lifeskim |
pubmed-article:11425270 | lifeskim:mentions | umls-concept:C0220908 | lld:lifeskim |
pubmed-article:11425270 | lifeskim:mentions | umls-concept:C0205183 | lld:lifeskim |
pubmed-article:11425270 | lifeskim:mentions | umls-concept:C0027775 | lld:lifeskim |
pubmed-article:11425270 | lifeskim:mentions | umls-concept:C0001914 | lld:lifeskim |
pubmed-article:11425270 | lifeskim:mentions | umls-concept:C2728259 | lld:lifeskim |
pubmed-article:11425270 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:11425270 | pubmed:dateCreated | 2001-6-26 | lld:pubmed |
pubmed-article:11425270 | pubmed:abstractText | A nested case-control study was conducted to identify risk factors for benign breast biopsies in 382 cases (women with a benign biopsy result) and 399 controls (women who had not undergone a biopsy) who were sampled from the Alberta breast cancer screening program. The breast biopsy specimens of the cases were reviewed by a panel of pathologists, and percent fibroglandular tissue density was assessed. The multivariable odds ratios for the risk of open benign breast biopsy associated with current cigarette smoking was 2.04 (95% CI 1.32-3.13), for ever regular smoking was 1.61 (1.20-2.16), and for passive smoking was 1.41 (0.99-2.02). A risk reduction was found for ever alcohol consumption (0.61 [0.44-0.85]). Some risk reductions were found when the highest and the lowest quintiles of total aerobic recreational activity were compared (0.71 [0.42-1.20]), stair climbing (0.61 [0.37-1.01]) and walking pace (0.13 [0.02-0.741). Lifestyle risk factors may be implicated in the continuum between detection of an abnormality on a screening mammogram and a breast biopsy specimen. By considering these risk factors, breast screening programs may be better able to identify those women who require a breast biopsy and reduce the number of benign breast biopsies. | lld:pubmed |
pubmed-article:11425270 | pubmed:language | eng | lld:pubmed |
pubmed-article:11425270 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11425270 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11425270 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11425270 | pubmed:issn | 0361-090X | lld:pubmed |
pubmed-article:11425270 | pubmed:author | pubmed-author:PageD LDL | lld:pubmed |
pubmed-article:11425270 | pubmed:author | pubmed-author:AlexanderFF | lld:pubmed |
pubmed-article:11425270 | pubmed:author | pubmed-author:HugiKK | lld:pubmed |
pubmed-article:11425270 | pubmed:author | pubmed-author:FriedenreichC... | lld:pubmed |
pubmed-article:11425270 | pubmed:author | pubmed-author:DanylukJJ | lld:pubmed |
pubmed-article:11425270 | pubmed:author | pubmed-author:BryantH EHE | lld:pubmed |
pubmed-article:11425270 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11425270 | pubmed:volume | 25 | lld:pubmed |
pubmed-article:11425270 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11425270 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11425270 | pubmed:pagination | 280-91 | lld:pubmed |
pubmed-article:11425270 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:11425270 | pubmed:meshHeading | pubmed-meshheading:11425270... | lld:pubmed |
pubmed-article:11425270 | pubmed:meshHeading | pubmed-meshheading:11425270... | lld:pubmed |
pubmed-article:11425270 | pubmed:meshHeading | pubmed-meshheading:11425270... | lld:pubmed |
pubmed-article:11425270 | pubmed:meshHeading | pubmed-meshheading:11425270... | lld:pubmed |
pubmed-article:11425270 | pubmed:meshHeading | pubmed-meshheading:11425270... | lld:pubmed |
pubmed-article:11425270 | pubmed:meshHeading | pubmed-meshheading:11425270... | lld:pubmed |
pubmed-article:11425270 | pubmed:meshHeading | pubmed-meshheading:11425270... | lld:pubmed |
pubmed-article:11425270 | pubmed:meshHeading | pubmed-meshheading:11425270... | lld:pubmed |
pubmed-article:11425270 | pubmed:meshHeading | pubmed-meshheading:11425270... | lld:pubmed |
pubmed-article:11425270 | pubmed:meshHeading | pubmed-meshheading:11425270... | lld:pubmed |
pubmed-article:11425270 | pubmed:meshHeading | pubmed-meshheading:11425270... | lld:pubmed |
pubmed-article:11425270 | pubmed:meshHeading | pubmed-meshheading:11425270... | lld:pubmed |
pubmed-article:11425270 | pubmed:meshHeading | pubmed-meshheading:11425270... | lld:pubmed |
pubmed-article:11425270 | pubmed:meshHeading | pubmed-meshheading:11425270... | lld:pubmed |
pubmed-article:11425270 | pubmed:meshHeading | pubmed-meshheading:11425270... | lld:pubmed |
pubmed-article:11425270 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11425270 | pubmed:articleTitle | Risk factors for benign breast biopsies: a nested case-control study in the Alberta breast screening program. | lld:pubmed |
pubmed-article:11425270 | pubmed:affiliation | Division of Epidemiology, Prevention and Screening, Alberta Cancer Board, Calgary. | lld:pubmed |
pubmed-article:11425270 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11425270 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11425270 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11425270 | lld:pubmed |